| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.37 | 0.004 |